Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications

 

Nanobiotechnology and Nanomedicine Companies

 

(Links listed alphabetically)

 
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
 

Showing results 151 - 175 of 301

 
Develops and manufactures acoustic droplet ejection (ADE) systems, a fully automated, non-contact, nozzle-free technology to dispense nanoliters of liquids.
Develops novel polymeric, nano-delivery systems for delivery of water-insoluble and poorly bio-available drugs.
Leonardo is the exclusive provider of a proprietary multistage drug delivery platform initially targeting the treatment of cancer. The first stage consists of silicon nanoparticles that are rationally designed to circumvent the biological barriers between injection and the target site. The non-toxic silicon nanoparticles can carry a variety of second stage delivery vehicles.
A cell culture/biotech company making strides in enhancing organ preservation and cell culturing at both room temperature and through cryopreservation. The LIFOR® technology is the nanoparticle component of the solution, which carries the oxygen or any type of drug or nutrient that the developers wish to place into the nanoparticle.
Lighthouse Biosciences' signature technology is the NanoLantern. The Lighthouse NanoLantern is a DNA-based system that targets a particular pathogen, and lights up when the pathogen is detected.
The biomedical division of Linari Engineering offers electrospinning devices, and bioreactors and incubators for cell cultures.
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
Develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a unique combination of sensitivity, reliability, flexibility and high throughput.
Provides integrated systems for nanotechnology-based cancer therapy.
MagnaMedics is active in the field of developing and commercializing Nano tools and systems for Life Science Research, analytical laboratories, medical diagnostics and therapies.
Develops tissue engineering products by using magnetic nanoparticles to overcome major problems associated with the ex vivo growth of human tissues and cells.
Makefield Therapeutics has licensed Intellectual Property covering a novel platform technology from Albert Einstein College of Medicine of Yeshiva University for the generation of powders comprised of hydrogel/glassy matrix (hybrid) nanoparticles that in a first application are delivering controlled and sustained therapeutic levels of gaseous nitric oxide
MSI's technology for multi-step multi-analyte chemiluminescent assays combines microfluidics, nanotechnology, and optoelectronics designed for both Immunoassay and Nucleic Acid Hybridization based applications.
The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.
Meda Biotech is a clinical-stage biopharmaceutical company developing a new class of Hybrid- Nanoengineering™ platform enables the design, engineering and manufacturing of Hybrid water soluble drugs with unprecedented control over drug properties to maximize trafficking to disease sites, dramatically enhancing efficacy while minimizing toxicities.
The company utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties.
A provider of microchip-based biosample preparation systems for the biodefense and genomics industries by exploiting its proprietary microfluidic and nanofluidic technologies.
MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical, drug metabolism, pharmacokinetic, formulation and immunoassay support services to pharmaceutical and biotech companies worldwide.
Micronics, Inc. is a leading developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. Capabilities include micro-nano assays.
Micronit Microfluidics focuses on developing, prototyping and manufacturing lab-on-a-chip products. Micronit has extensive experience supplying microfluidic solutions to the life sciences industry. Capabilities include nanofluidic channels (depth down to 100 nm).
The MicroTransponder, Inc. technology portfolio consists of a wireless micro-system that can interface with peripheral nerves and a host of biochemical micro/nano- sensors.
Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.
Mindseeds Laboratories is a start-up company focused on research and engineering of innovative platforms for single-cell processing, manipulation and analysis.
Develops nanoparticle based in vivo delivery applications.
 
 
 
left arrowBack to Nanotechnology Links Directory